Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An open label phase II treatment trial (single group assignment) evaluating Enzalutamide + Fecal microbiota transplantation (FMT) + Pembrolizumab in patients with metastatic Prostate cancer
Primary outcome measures:
The percentage of participants who experienced a PSA decline of 50% or more at any point during the study following FMT.
…